Announcements
View latest announcements here.
2096 items
2 October 2026
First Etomidate Vaporiser Pod Importer Sentenced to Three Years' Jail and Five Strokes of the Cane
Audiences
Consumer
Healthcare professional
Industry member
30 September 2026
HSA Charges 33-year-old and 18-year-old Male for Alleged Importation and Possession for Purpose of Supply of Etomidate Vaporiser Pods
30 September 2026
Regulatory Updates for Therapeutic Product Registration
Audiences
Industry member
Product type
Therapeutic Products
As part of HSA’s ongoing initiative to improve regulatory efficiency and enhance clarity in our regulatory requirements and processes, Therapeutic Products Branch (TPB) is pleased to update industry on the following:
30 September 2026
Slides, FAQ & Resources – Virtual Sharing Session (24 September 2026)
Audiences
Industry member
Product type
Medical devices
HSA organised a zoom webinar on Concurrent Change Notification and Premarket Submission Checklist for Medical Device Product Registration on 24 September 2026.
25 September 2026
Risks of obtaining prescription medicines and unapproved injectable peptides through unauthorised channels
Audiences
Consumer
Healthcare professional
Industry member
Product type
Others
Therapeutic Products
22 September 2026
HSA Charges 41-year-old Male for Alleged Trafficking of Etomidate Vaporiser Pods
Audiences
Consumer
Healthcare professional
Industry member
Product type
Tobacco control
18 September 2026
NU SKIN ageLOC Dermatic Effects
Audiences
Healthcare professional
Industry member
Product type
Cosmetic products
Retail-level recall of NU SKIN ageLOC Dermatic Effects (all batches) due to theophylline detected.
18 September 2026
ADR News Bulletin 2026 September (Volume 28 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
17 September 2026
HSA Extends Partnerships to Speed Access to Health Innovations Across Key Markets in Africa, Malaysia and Saudi Arabia
Audiences
Consumer
Healthcare professional
Industry member
Product type
Others
Therapeutic Products
15 September 2026
Risk of vitamin B6 deficiency and associated seizures with carbidopa/levodopa or benserazide/levodopa
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
